||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 556 active entries
5429 Bay Harbor Drive, BOX-4509
United States of America, Indiana
Phone: +1 317 703 0614
BiologicsCorp focuses on recombinant protein production and provides GUARANTEED protein expression service and thousands of recombinant proteins in house.
Recombinant Proteins Products
BIC (BiologicsCorp) has decades of experience in cytokines, allowing us to provide you with the best quality recombinant protein products. With over 2,000 protein experience, BiologicsCorp has developed and refined innovative protocols to ensure quality, reliability and consistency. At BiologicsCorp, our goal is to provide scientists and researchers with the best biological reagents and tools available, ultimately being a partner you can trust and depend on to help achieve your goals quicker at a lower cost.
Recombinant Protein Services
BIC (BiologicsCorp) provides high-quality, cost-effective, custom protein service. We excel on all aspects of the process (gene synthesis, cell culture, protein expression and purification and so on) and have successfully delivered purified proteins to countless customers, with an over 95% on-time rate. Leading the CRO industry, we have the best technical support and focus on quality as well as cost-saving for customers. We are determined to provide the best product in the most cost-effective way, therefore to free up your time and resources for your specialty.
Custom Antibody Services One-stop antibody service: from gene, through polypeptide/protein production, till high-titer antibody generation. Based on our polypeptide/protein production and proprietary technology, we guarantee to deliver polyclonal antibodies with a titer of 1:50,000 or above (ELISA) and positive protein immunoblot results. We may produce polyclonal antibodies in rabbit, chicken, rat, or goat. Our monoclonal antibody service, either from polypeptide or protein antigens, is available with either rat or mouse hybridoma development options.
Last update of this entry: September 01, 2016